This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Annabelle Bruyndonckx
Counsel at Simmons & Simmons LLP, Belgium

Profile

Annabelle Bruyndonckx joined Simmons & Simmons in 2013, after more than 14 years at another international law firm, where she headed the Pharmaceuticals & Healthcare group. She was admitted to the Brussels bar in 1998 and was a part-time lecturer at the Catholic University of Louvain from 1997 to 2003.

Annabelle specialises in regulatory and compliance advice on behalf of medical technology and digital health businesses, pharmaceutical and consumer health companies and significant players in other highly regulated industries. With a legal career spanning 22 years, she advises on a wide range of issues from the R&D phase and product qualification/classification, to (early) market access (pricing and reimbursement) and (pharmaco) vigilance, covering all aspects relating to distribution, advertising, tendering and liability issues. Annabelle frequently liaises with Belgian/EU regulators and industry associations on behalf of industry players. In healthcare compliance, Annabelle has significant experience in local and global cross-border projects, approval and transparency procedures, SOP implementation, and bribery/anti-gift measures.

Today, Annabelle is the head of the Educational Group of the Regulatory Chapter (BRAS) of Healixia, where she organizes training sessions on various pharma and medical devices related topics. Annabelle is also a member of the European Food Law Association (EFLA) and the Belgian public procurement club. She is frequently invited to speak at international conferences on various topics and has published numerous articles in legal and trade journals relating to various regulatory and compliance matters specific to the Health & Life Sciences sectors.

Agenda Sessions

  • Navigating the ‘Grey Zone’ when Interacting with HCPs and HCOs

    15:25